BMO Capital Reiterates Silence Therapeutics (SLN) at Outperform, 'expect a positive Pelacarsen readout to drive 100-200%+ upside" Dec 2, 2024 06:04AM
BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN) Nov 19, 2024 02:55PM
BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN) Aug 16, 2024 07:51AM
BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN) Jun 17, 2024 08:56AM
BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN) May 28, 2024 05:14AM


Mar 13, 2024 11:01AM BMO Capital Reiterates Silence Therapeutics (SLN) as Top Pick, 'buy the dip'
Feb 13, 2024 05:35AM BMO Capital Pounds Table on Silence Therapeutics (SLN), New Top Pick
Jan 31, 2024 03:46AM BMO Capital Starts Silence Therapeutics (SLN) at Outperform, 'a key player to watch'